- Home
- TSI vs ARAY Comparison
TSI vs ARAY Comparison
Compare TSI & ARAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSI
- ARAY
- Stock Information
- Founded
- TSI 1987
- ARAY 1990
- Country
- TSI United States
- ARAY United States
- Employees
- TSI N/A
- ARAY N/A
- Industry
- TSI Investment Managers
- ARAY Medical/Dental Instruments
- Sector
- TSI Finance
- ARAY Health Care
- Exchange
- TSI Nasdaq
- ARAY Nasdaq
- Market Cap
- TSI 234.6M
- ARAY 229.3M
- IPO Year
- TSI N/A
- ARAY 2007
- Fundamental
- Price
- TSI $4.88
- ARAY $1.36
- Analyst Decision
- TSI
- ARAY
- Analyst Count
- TSI 0
- ARAY 0
- Target Price
- TSI N/A
- ARAY N/A
- AVG Volume (30 Days)
- TSI 106.8K
- ARAY 1.3M
- Earning Date
- TSI 01-01-0001
- ARAY 08-13-2025
- Dividend Yield
- TSI 7.46%
- ARAY N/A
- EPS Growth
- TSI N/A
- ARAY N/A
- EPS
- TSI N/A
- ARAY 0.01
- Revenue
- TSI N/A
- ARAY $465,251,000.00
- Revenue This Year
- TSI N/A
- ARAY $3.87
- Revenue Next Year
- TSI N/A
- ARAY $0.09
- P/E Ratio
- TSI N/A
- ARAY $204.83
- Revenue Growth
- TSI N/A
- ARAY 8.06
- 52 Week Low
- TSI $4.48
- ARAY $1.14
- 52 Week High
- TSI $4.87
- ARAY $2.95
- Technical
- Relative Strength Index (RSI)
- TSI 59.90
- ARAY 43.72
- Support Level
- TSI $4.80
- ARAY $1.21
- Resistance Level
- TSI $4.97
- ARAY $1.29
- Average True Range (ATR)
- TSI 0.04
- ARAY 0.06
- MACD
- TSI 0.00
- ARAY 0.01
- Stochastic Oscillator
- TSI 84.21
- ARAY 75.06
About TSI TCW Strategic Income Fund Inc.
Tcw Strategic Income Fund Inc operates as a closed-end management investment company. Its investment objective is to seek a total return comprised of current income and capital appreciation by investing in a wide range of securities. The company invests in a range of industries, such as airlines, banks, beverages, biotechnology, chemicals, computers, diversified financial services, entertainment and others.
About ARAY Accuray Incorporated
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, innovative treatment solutions which set the standard of radiation therapy care with the aim of helping patients live better lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.